Sept. 4, 2024
In this episode, Scott Becker explores five emerging drug trends, including the rise of microdosing psychedelics for joint pain, expanded uses of GLP-1s, the complexities of cannabis testing, evolving approaches to adult ADHD treatment, and the booming medical spa industry driven by private equity investments.
